drugset / Trial / NCT00215176

Modafinil for Atypical Depression

NCT00215176

Phase 2/3 Completed 65 enrolled Duke University Cephalon · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of the study are to: 1) evaluate the short-term efficacy and safety of modafinil in atypical depression; and 2) to evaluate the efficacy of modafinil in preventing relapse of atypical depression. The hypothesis is that modafinil is safe and effective in the treatment of atypical depression.

Timeline

Start
2003-02
Primary completion
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule